Cardiometabolic multimorbidity (CMM), defined as the coexistence of at least two cardiometabolic diseases (CMDs, including myocardial infarction, diabetes, and stroke), has been established as an important risk factor for adverse cardiovascular outcomes [1-2]. However, the differential impact of varying CMM burde...
J. Gao, Y.-H. Wang, Y.-Q. Li et al.· European Heart Journal· 0 citations
Prepregnancy obesity is a well-established risk factor for adverse pregnancy outcomes (APOs) and future cardiovascular metabolic disease. However, previous studies often focused on isolated APOs or surrogate markers rather than confirmed clinical endpoints. Furthermore, APOs rarely occur in isolation but manifest...
L. Zuo, Y. Fang, X. Wang et al.· European Heart Journal· 0 citations
Body mass index (BMI) is a modifiable prognostic factor in non-ST-segment elevation myocardial infarction (NSTEMI). Investigating the impact of BMI on short- and long-term prognosis in patients with NSTEMI can inform clinical management and improve patient outcomes[1, 2].
This study aimed to investigate th...
J. Gao, Y.-Q. Li, Y.-H. Wang et al.· European Heart Journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.